ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,243, issued on Aug. 5, was assigned to UroPharma Ltd. (Norfolk, Great Britain).
"Intermittent intravesical therapeutic administration system" was invented by Howard Shapland (Woodton, Great Britain), Scott Glickman (Kingswood, Great Britain) and Gabriel Korn (Norwich, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "An intravesical intermittent instillation catheter includes a tube containing a urinary lumen and an instillation lumen. The proximal end has a set of drainage eyelets, formed in a wall of the tube, that are in communication with the urinary lumen as well as a set of instillation eyelets, formed at a tip of the proximal end, i...